This site is intended for health professionals only!

Published on 1 July 2007

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Fruit supplements “slow blindness”
German court revokes Pfizer patent
Tibotec releases final results of Phase 3 REALIZE study
UKCPA position statement on AF management
Treating cancer: more of a science, less of an art

Monitoring of hazardous drugs

teaser

Jean-Fran



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
UK’s MHRA hails counterfeit drugs conviction
Individualised therapeutic vaccines for B-cell NHL
HRT linked to higher ovarian cancer risk
Childhood obesity branded “everyone’s business” by new report
ASCEND data demonstrate superiority of Enbrel versus sulphasalazine